Human Interferon IFNa2b

Malignant carcinoid tumors, a symptom of carcinoid syndrome, presented a therapeutic challenge for many years until the introduction of interferon treatment in 1982 by Oberg and Eriksson [51]. They reported that 47 out of 111 patients (42%) treated with interferon- / (median dose of 6 mega-units (MU) of interferon-a, five 

In the Petit Havana transgenic lines, chloroplast genome homoplasmy occurred in the first generation, and this corresponded to the highest level of IFNa2b expression. ELISAs revealed IFNa2b levels of up to 18.8% TSP in Petit Havana and up to 12.5% TSP in LAMD-609. 

---